Treatment adherence with antipsychotic medications in bipolar disorder
dc.contributor.author | Sajatovic, Martha | en_US |
dc.contributor.author | Valenstein, Marcia | en_US |
dc.contributor.author | Blow, Frederic C. | en_US |
dc.contributor.author | Ganoczy, Dara | en_US |
dc.contributor.author | Ignacio, Rosalinda V. | en_US |
dc.date.accessioned | 2010-06-01T20:57:29Z | |
dc.date.available | 2010-06-01T20:57:29Z | |
dc.date.issued | 2006-06 | en_US |
dc.identifier.citation | Sajatovic, Martha; Valenstein, Marcia; Blow, Frederic C; Ganoczy, Dara; Ignacio, Rosalinda V (2006). "Treatment adherence with antipsychotic medications in bipolar disorder." Bipolar Disorders 8(3): 232-241. <http://hdl.handle.net/2027.42/74052> | en_US |
dc.identifier.issn | 1398-5647 | en_US |
dc.identifier.issn | 1399-5618 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74052 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16696824&dopt=citation | en_US |
dc.format.extent | 117423 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2006 Blackwell Munksgaard | en_US |
dc.subject.other | Atypical Antipsychotic | en_US |
dc.subject.other | Bipolar Disorder | en_US |
dc.subject.other | Compliance | en_US |
dc.subject.other | Treatment Adherence | en_US |
dc.title | Treatment adherence with antipsychotic medications in bipolar disorder | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Psychology | en_US |
dc.subject.hlbtoplevel | Social Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. | en_US |
dc.contributor.affiliationother | Case Western Reserve University School of Medicine, Cleveland, OH | en_US |
dc.contributor.affiliationother | Health Services Research and Development Service and Serious Mental Illness Treatment Research and Evaluation Center (SMITREC), Veterans Affairs Ann Arbor Health System | en_US |
dc.identifier.pmid | 16696824 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74052/1/j.1399-5618.2006.00314.x.pdf | |
dc.identifier.doi | 10.1111/j.1399-5618.2006.00314.x | en_US |
dc.identifier.source | Bipolar Disorders | en_US |
dc.identifier.citedreference | Colom F, Vieta E. Treatment adherence in bipolar patients. Clinical Approaches Bipolar Disorders 2002; 1: 49 – 56. | en_US |
dc.identifier.citedreference | Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48: 1082 – 1088. | en_US |
dc.identifier.citedreference | Scott J. Predicting medication non-adherence in severe affective disorders. Acta Neuropsychiatr 2000; 12: 128 – 130. | en_US |
dc.identifier.citedreference | Muller-Oerlinghausen B, Muser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992; 25: 261 – 269. | en_US |
dc.identifier.citedreference | Frank E, Prien RF, Kupfer DJ, Alberts L. Implications of noncompliance on research in affective disorders. Psychopharmacol Bull 1985; 21: 37 – 42. | en_US |
dc.identifier.citedreference | Goodwin FK, Jamison KR eds. Manic-depressive Illness. New York: Oxford University Press, 1990. | en_US |
dc.identifier.citedreference | Jamison KR, Gerner RH, Goodwin FK. Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry 1979; 36 ( 8 Spec No ): 866 – 869. | en_US |
dc.identifier.citedreference | Miklowitz DJ. Longitudinal outcome and medication noncompliance among manic patients with and without mood-incongruent psychotic features. J Nerv Ment Dis 1992; 180: 703 – 711. | en_US |
dc.identifier.citedreference | Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated to treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000; 61: 549 – 555. | en_US |
dc.identifier.citedreference | Maarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry 1988; 21: 121 – 125. | en_US |
dc.identifier.citedreference | Comtois KA, Ries R, Armstrong HE. Case manager ratings of the clinical status of dually diagnosed outpatients. Hosp Community Psychiatry 1994; 45: 568 – 573. | en_US |
dc.identifier.citedreference | Weiss RD, Greenfield SF, Najavits LM et al. Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry 1998; 59: 172 – 174. | en_US |
dc.identifier.citedreference | Shemesh E, Yehuda R, Milo O et al. Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med 2004: 66: 521 – 526. | en_US |
dc.identifier.citedreference | Schumann C, Lenz G, Berghofer A, Muller-Oerlinghausen B. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res 1999; 89: 247 – 257. | en_US |
dc.identifier.citedreference | Perlick DA, Rosenheck RA, Kaczynski R, Kozma L. Medication non-adherence in bipolar disorder: a patient-centered review of research findings. Clin Approach Bipolar Disord 2004; 3: 56 – 64. | en_US |
dc.identifier.citedreference | Sajatovic M, Hrouda D, Davies M. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv 2004; 55: 264 – 269. | en_US |
dc.identifier.citedreference | American Psychiatric Association. Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision). Washington, DC: American Psychiatric Press, 2002. | en_US |
dc.identifier.citedreference | Nemeroff CB. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry 2000; 61 ( Suppl. 13 ): 19 – 25. | en_US |
dc.identifier.citedreference | Calabrese JR, Shelton MD, Rapport DJ, Kimmel SE. Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry 2002; 63 ( Suppl. 3 ): 5 – 9. | en_US |
dc.identifier.citedreference | Keck PE, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The Expert Consensus Guideline Series: Treatment of Bipolar Disorder 2004. Postgraduate Medicine Special Report 2004; December: 1 – 116. | en_US |
dc.identifier.citedreference | Gilmer TP, Dolder CR, Lacro JP et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004; 161: 692 – 699. | en_US |
dc.identifier.citedreference | Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 2001; 52: 805 – 811. | en_US |
dc.identifier.citedreference | Valenstein M, Blow FC, Copeland LA et al. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull 2004; 30: 255 – 264. | en_US |
dc.identifier.citedreference | Valenstein M, Copeland LA, Blow FC et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002; 40: 630 – 639. | en_US |
dc.identifier.citedreference | DiMatteo MR. Variations in patients adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200 – 209. | en_US |
dc.identifier.citedreference | Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218 – 1224. | en_US |
dc.identifier.citedreference | Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002; 105: 164 – 172. | en_US |
dc.identifier.citedreference | Mukherjee S, Rosen AM, Shukla S. Acceptance by patients of maintenance lithium treatment. Lithium 1993; 2: 63 – 69. | en_US |
dc.identifier.citedreference | Jamison KR. Medication compliance. In: Goodwin FK, Jamison KR, eds. Manic Depressive Illness. Oxford: Oxford University Press, 1990: 756 – 757. | en_US |
dc.identifier.citedreference | Lenzi A, Lazzerini F, Placidi GF, Cassano GB, Akiskal HS. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Pharmacopsychiatry 1989; 22: 34 – 37. | en_US |
dc.identifier.citedreference | Keck PE Jr, McElroy SL, Strakowski SM, Bourne ML, West SA. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 1997; 33: 87 – 91. | en_US |
dc.identifier.citedreference | Connelly CE, Davenport YB, Nurnberger JI Jr. Adherence to treatment regimen in a lithium carbonate clinic. Arch Gen Psychiatry 1982; 39: 585 – 588. | en_US |
dc.identifier.citedreference | Kucera-Bozarth K, Beck NC, Lyss L. Compliance with lithium regimens. J Psychosoc Nurs Ment Health Serv 1982; 20: 11 – 15. | en_US |
dc.identifier.citedreference | Danion JM, Neunreuther C, Krieger-Finance F, Imbs JL, Singer L. Compliance with long-term lithium treatment in major affective disorders. Pharmacopsychiatry 1987; 20: 230 – 231. | en_US |
dc.identifier.citedreference | Sajatovic M, Davies M, Bauer MS, McBride L, Hays RW, Jenkins J. Attitudes regarding the collaborative practice model and treatment adherence among individuals with bipolar disorder. Compr Psychiatry 2005; 46: 272 – 7. | en_US |
dc.identifier.citedreference | Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 2002; 63: 384 – 390. | en_US |
dc.identifier.citedreference | Keck PE Jr, McElroy SL, Strakowski SM et al. Factors associated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry 1996; 57: 292 – 297. | en_US |
dc.identifier.citedreference | Sajatovic M, Bauer M, Kilbourne A, Vertrees J, Williford W. Self-reported medication adherence among veterans with bipolar disorder. Psychiatr Serv 2006; 57: 56 – 62. | en_US |
dc.identifier.citedreference | Sajatovic M, Shelton MD, Elhaj O et al. Treatment Adherence in Patients with Rapid Cycling Bipolar Disorder: Results from a Clinical Trials Setting. American Psychiatric Association Annual meeting. Poster presentation, Atlanta, Georgia; 2005. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.